MRM Wins Novartis Aclasta European CRM Business

Share this article:
Novartis tapped MRM Worldwide, an interactive and relationship marketing company, to undertake European patient communications for its Aclasta CRM program, it was announced yesterday.


Aclasta is an annual infusion for the treatment of Paget's disease and is in the third phase of clinical trials for other metabolic bone disorders such as osteoporosis.


Novartis said it also is considering letting MRM Worldwide pitch for all of its global CRM opportunities.


MRM Partners, a unit of McCann Worldgroup, which is owned by Interpublic Group of Companies, has 62 offices in 37 countries, more than 1,700 employees and clients such as Coca-Cola, Dell, General Motors, Intel, Royal Bank of Scotland Group, Tesco, UPS, Unilever and Vodafone.


Share this article:
You must be a registered member of Direct Marketing News to post a comment.
close

Next Article in Data/Analytics

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs:

Featured Listings

More in Data/Analytics

MeritDirect Opens San Jose Office

MeritDirect Opens San Jose Office

A force in direct mail, the company looks to expand its digital data services with a footprint in Silicon Valley.

Neustar Decides to Hand Data Over to its Clients

Neustar Decides to Hand Data Over to its ...

AK Media Insights Pro turns data over to marketers to create business-specific aggregations, integrate offline efforts, and probe deeper into their sales funnels.

Arthur Hughes, Who Wrote the Book on Database Marketing, Dies at 86

Arthur Hughes, Who Wrote the Book on Database ...

First published in the early days of the Web, Arthur Middleton Hughes's Strategic Database Marketing remains a bible for direct marketers.